Vol 20, No 2 (2015)
Original research articles
Published online: 2015-03-01

open access

Page views 334
Article views/downloads 320
Get Citation

Connect on Social Media

Connect on Social Media

Integral dose: Comparison between four techniques for prostate radiotherapy

Krzysztof Ślosarek1, Wojciech Osewski2, Aleksandra Grządziel1, Michał Radwan1, Łukasz Dolla1, Marta Szlag1, Małgorzata Stąpór-Fudzińska1
DOI: 10.1016/j.rpor.2014.10.010
Rep Pract Oncol Radiother 2015;20(2):99-103.

Abstract

Aim

Comparisons of integral dose delivered to the treatment planning volume and to the whole patient body during stereotactic, helical and intensity modulated radiotherapy of prostate.

Background

Multifield techniques produce large volumes of low dose inside the patient body. Delivered dose could be the result of the cytotoxic injuries of the cells even away from the treatment field. We calculated the total dose absorbed in the patient body for four radiotherapy techniques to investigate whether some methods have a potential to reduce the exposure to the patient.

Materials and methods

We analyzed CyberKnife plans for 10 patients with localized prostate cancer. Five alternative plans for each patient were calculated with the VMAT, IMRT and TomoTherapy techniques. Alternative dose distributions were calculated to achieve the same coverage for PTV. Integral Dose formula was used to calculate the total dose delivered to the PTV and whole patient body.

Results

Analysis showed that the same amount of dose was deposited to the treated volume despite different methods of treatment delivery. The mean values of total dose delivered to the whole patient body differed significantly for each treatment technique. The highest integral dose in the patient's body was at the TomoTherapy and CyberKnife treatment session. VMAT was characterized by the lowest integral dose deposited in the patient body.

Conclusions

The highest total dose absorbed in normal tissue was observed with the use of a robotic radiosurgery system and TomoTherapy. These results demonstrate that the exposure of healthy tissue is a dosimetric factor which differentiates the dose delivery methods.

Article available in PDF format

View PDF Download PDF file



Reports of Practical Oncology and Radiotherapy